THE RISK FACTORS OF COVID-19 ADVERSE OUTCOME AND FOLLOW-UP TWO-YEAR SURVIVAL RATE IN PATIENTS ON MAINTENANCE HEMODIALYSIS

https://storage.unitedwebnetwork.com/files/1099/1808750aadf0b9d110087185c69bad62.pdf
THE RISK FACTORS OF COVID-19 ADVERSE OUTCOME AND FOLLOW-UP TWO-YEAR SURVIVAL RATE IN PATIENTS ON MAINTENANCE HEMODIALYSIS
Eugene
Zeltyn-Abramov
Mariana Lysenko gkb52@zdrav.mos.ru 1. Moscow City Clinical Hospital 52, Russian Federation, 2. Pirogov Russian National Research Medical University, Moscow, Russian Federation MD, PhD, Chief of MCCH52 Moscow
Ruslan Trushkin uro52@mail.ru Moscow City Clinical Hospital 52, Russian Federation MD, PhD, Head of Urology Department Moscow
Svetlana Kondrashkina kras6989@mail.ru Moscow City Clinical Hospital 52, Russian Federation MD, Cardiologist Moscow
Natalya Belavina natbelavina@mail.ru Moscow City Clinical Hospital 52, Russian Federation MD, PhD, Сardio-Nephrology Laboratory Moscow
Nataliya Klochkova natalidoc1978@mail.ru 1. Moscow City Clinical Hospital 52, Russian Federation, 2. Pirogov Russian National Research Medical University, Moscow, Russian Federation MD, Ultrasound Diagnostic Department Moscow
Angela Ushakova Anzhela_52@inbox.ru Moscow City Clinical Hospital 52, Russian Federation MD, Head of Hemodialysis Department Moscow